Insights into Drug Precipitation Kinetics during In Vitro Digestion of a Lipid-Based Drug Delivery System Using In-Line Raman Spectroscopy and Mathematical Modeling
暂无分享,去创建一个
[1] P. Geladi,et al. Linearization and Scatter-Correction for Near-Infrared Reflectance Spectra of Meat , 1985 .
[2] T. Rades,et al. Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate. , 2010, Journal of pharmaceutical sciences.
[3] H. Kristensen,et al. A dynamic in vitro lipolysis model. II: Evaluation of the model. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] A. Hoffman,et al. Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats , 2006, Pharmaceutical Research.
[5] M. Kuentz,et al. Study of drug concentration effects on in vitro lipolysis kinetics in medium-chain triglycerides by considering oil viscosity and surface tension. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] Christopher J H Porter,et al. Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products , 2002, The Journal of pharmacy and pharmacology.
[7] Ben J. Boyd,et al. Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation , 2004, Pharmaceutical Research.
[8] B. Anderson,et al. CHEMICAL AND RELATED FACTORS CONTROLLING LIPID SOLUBILITY , 1999 .
[9] B. Boyd,et al. Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug. , 2005, Journal of pharmaceutical sciences.
[10] Dallas B. Warren,et al. Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[11] S. Byrn,et al. Analysis of the Effect of Particle Size on Polymorphic Quantitation by Raman Spectroscopy , 2006, Applied spectroscopy.
[12] J. Rantanen,et al. Structural elucidation of rapid solution-mediated phase transitions in pharmaceutical solids using in situ synchrotron SAXS/WAXS. , 2012, Molecular pharmaceutics.
[13] F. Carrière,et al. Understanding the lipid-digestion processes in the GI tract before designing lipid-based drug-delivery systems. , 2012, Therapeutic delivery.
[14] M. Kuentz. Lipid-based formulations for oral delivery of lipophilic drugs. , 2012, Drug discovery today. Technologies.
[15] G. Edwards,et al. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. , 2004, Journal of pharmaceutical sciences.
[16] C. Reppas,et al. Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of danazol across Caco-2 cell monolayers. , 2012, Molecular pharmaceutics.
[17] Patrick Augustijns,et al. Excipient-mediated supersaturation stabilization in human intestinal fluids. , 2011, Molecular pharmaceutics.
[18] B. Griffin,et al. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations. , 2008, Advanced drug delivery reviews.
[19] F. Carrière,et al. Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. , 2007, Biochimica et biophysica acta.
[20] C. W. Garner. Boronic acid inhibitors of porcine pancreatic lipase. , 1980, The Journal of biological chemistry.
[21] A. Müllertz,et al. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations. , 2012, Journal of pharmaceutical sciences.
[22] A. Müllertz,et al. In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems. , 2011, International journal of pharmaceutics.
[23] Arik Dahan,et al. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[24] A. Müllertz,et al. Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion. , 2012, Molecular pharmaceutics.
[25] F. Puel,et al. In-line monitoring of partial and overall solid concentration during solvent-mediated phase transition using Raman spectroscopy. , 2006, International journal of pharmaceutics.
[26] P. Annaert,et al. Drug precipitation-permeation interplay: supersaturation in an absorptive environment. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[27] R Holm,et al. Supersaturated Self-Nanoemulsifying Drug Delivery Systems (super-SNEDDS) , 2012 .
[28] C. Porter,et al. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.
[29] D. Hauss,et al. Oral lipid-based formulations : enhancing the bioavailability of poorly water-soluable drugs , 2007 .
[30] C. Pouton,et al. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. , 2009, Journal of pharmaceutical sciences.
[31] Frans van den Berg,et al. Review of the most common pre-processing techniques for near-infrared spectra , 2009 .
[32] J. S. Pedersen,et al. Structural Development of Self Nano Emulsifying Drug Delivery Systems (SNEDDS) During In Vitro Lipid Digestion Monitored by Small-angle X-ray Scattering , 2007, Pharmaceutical Research.
[33] A. Hermetter,et al. Identification of various lipolytic enzymes in crude porcine pancreatic lipase preparations using covalent fluorescent inhibitors , 2004, Biotechnology and bioengineering.
[34] P. H. Araújo,et al. Spectroscopic on-line monitoring of reactions in dispersed medium: chemometric challenges. , 2007, Analytica chimica acta.
[35] J. Patton,et al. Watching fat digestion. , 1979, Science.
[36] W. Bensch,et al. In-situ monitoring of the formation of crystalline solids. , 2011, Angewandte Chemie.
[37] M. Mazzotti,et al. Quantitative Application of in Situ ATR-FTIR and Raman Spectroscopy in Crystallization Processes , 2008 .
[38] Dimo Kashchiev,et al. Nucleation : basic theory with applications , 2000 .
[39] A Müllertz,et al. A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[40] Lynne S. Taylor,et al. Crystallization monitoring by Raman spectroscopy: Simultaneous measurement of desupersaturation profile and polymorphic form in flufenamic acid systems , 2005 .
[41] G. Edwards,et al. Increasing the Proportional Content of Surfactant (Cremophor EL) Relative to Lipid in Self-emulsifying Lipid-based Formulations of Danazol Reduces Oral Bioavailability in Beagle Dogs , 2007, Pharmaceutical Research.
[42] Anette Müllertz,et al. Colloidal Structures in Media Simulating Intestinal Fed State Conditions with and Without Lipolysis Products , 2009, Pharmaceutical Research.
[43] Christos Reppas,et al. Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[44] G. Edwards,et al. Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems. , 2012, Molecular pharmaceutics.
[45] Jean-David Rodier,et al. Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases. , 2008, Biochimica et biophysica acta.
[46] M. Mazzotti,et al. In Situ Monitoring and Modeling of the Solvent-Mediated Polymorphic Transformation of l-Glutamic Acid , 2006 .
[47] F. Mattson,et al. THE DIGESTION AND ABSORPTION OF TRIGLYCERIDES. , 1964, The Journal of biological chemistry.
[48] B. Kowalski,et al. Partial least-squares regression: a tutorial , 1986 .
[49] A. Müllertz,et al. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies , 2010, The Journal of pharmacy and pharmacology.
[50] M. Kuentz,et al. Comparison of high-resolution ultrasonic resonator technology and Raman spectroscopy as novel process analytical tools for drug quantification in self-emulsifying drug delivery systems. , 2012, Journal of pharmaceutical and biomedical analysis.
[51] J. H. T. Horst,et al. Quantitative Measurement of the Polymorphic Transformation of l-Glutamic Acid Using In-Situ Raman Spectroscopy , 2004 .
[52] Georgios Imanidis,et al. Advancing in‐vitro drug precipitation testing: new process monitoring tools and a kinetic nucleation and growth model , 2011, The Journal of pharmacy and pharmacology.
[53] D. Kashchiev,et al. Review: Nucleation in solutions revisited , 2003 .
[54] A. Müllertz,et al. Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity. , 2010, Journal of pharmaceutical sciences.
[55] B. Boyd,et al. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. , 2003, Journal of pharmaceutical sciences.
[56] C. Porter,et al. Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. , 2001, Journal of pharmaceutical and biomedical analysis.
[57] R. Barnes,et al. Standard Normal Variate Transformation and De-Trending of Near-Infrared Diffuse Reflectance Spectra , 1989 .
[58] Ping Gao,et al. Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption. , 2009, Journal of pharmaceutical sciences.
[59] A. Kuksis,et al. Studies on the substrate specificity of purified human milk lipoprotein lipase , 1982, Lipids.
[60] G. Edwards,et al. Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. , 2008, Journal of pharmaceutical sciences.